S Gastrointestinal And Liver Disease 12th Edition Guide

covering endoscopic techniques like balloon dilatation and stent placement. Reference Details Elsevier Health Sciences Publication Date 10–15 December 2025 978-0443116575 Page Count Approx. 2,500–3,700 pages (2-Volume Set) Target Audience

The 12th edition remains available for purchase at major retailers like Amazon , Barnes & Noble , and VitalSource .

Up-to-date guidance on endoscopy, advanced imaging, radiologic interventions, and surgical approaches.

, such as endoscopic sleeve gastroplasty, reflecting the gastroenterologist's growing role in obesity management. Precision Hepatology and Non-Invasive Staging s gastrointestinal and liver disease 12th edition

Information on the anticipated release date, if you're looking for future updates. Let me know how I can help you find more information.

For clinicians, institutional buyers, and trainees building a medical library, the physical and digital formats of this definitive reference balance immense depth with structural accessibility. Elsevier Science Health Science Publication Date December 10, 2025 Page Count 2,560 pages (Print Version) Format Options 2-Volume Hardcover Set & VitalSource eTextbook ISBN-13 978-0443116575 Key Accolade Selected as an Essential Purchase for Doody's Core Titles Critical Editorial Evolution

The highlights the move toward personalized medicine. It emphasizes the importance of understanding the molecular landscape of tumors and the genetic factors influencing liver disease susceptibility. Let me know how I can help you find more information

For over 50 years, Sleisenger and Fordtran's Gastrointestinal and Liver Disease has served as the definitive reference for gastroenterology and hepatology professionals worldwide. The 12th edition (published December 2025) continues this legacy, offering a comprehensive, two-volume masterwork that synthesizes the expertise of hundreds of global leaders to provide up-to-date information on the diagnosis, management, and treatment of gastrointestinal and liver diseases.

A distinguishing feature of this edition is its inclusion of data regarding the SARS

Sleisenger and Fordtran's Gastrointestinal and Liver Disease including mucosal immunology

remains the definitive "gold standard" reference for the field. Scheduled for release in , this edition transitions to a new senior editorial team led by Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox . Key Updates & New Features

This section covers foundational knowledge, including mucosal immunology, enteric microbiota, cellular growth, and psychosocial issues in GI care. 2. Nutrition and Metabolism